Zus Health Pitch Deck: All 29 Slides + Teardown

Executive Summary: The Infrastructure for Information Speed

Zus Health entered the market with a formidable pedigree, led by Jonathan Bush, the co-founder of athenahealth. In their 2024 Series B pitch deck, the company tackles one of the most persistent 'white whales' in American healthcare: interoperability. The deck, spanning 29 slides, outlines a vision to move from a world of 'fax and mail' medical records to a real-time, universal health profile. With a reported $40M raised in this round, the presentation focuses heavily on the transition from a technical tool to a financial engine for providers and EHR vendors.

Slide 1-3: Vision and Mission

The deck opens with a portrait of CEO Jonathan Bush, a move that leverages his significant reputation in the health-tech space. Slide 3 introduces the core thesis: healthcare is experiencing a 'goldilocks moment' where the demand for 'information speed' has finally met the technical capability to deliver it. The mission is stated clearly: 'Catalyze healthcare’s greatest innovators.' This positioning is crucial; Zus is not trying to be the provider, but the platform that enables providers to function efficiently.

Slide 7: The Manual Burden of Modern Medicine

Slide 7 provides the 'Problem' context through three personas: Patients, Clinical Staff, and Developers. The metrics here are compelling. Zus claims that 60% of patient intake questions could be pre-populated if data were shared effectively. The slide highlights the absurdity of the status quo, where clinical teams still rely on 'phone, fax and mail' for history, and developers struggle with data types that have 'up to 14 different terminologies.' This slide effectively bridges the gap between administrative frustration and technical complexity.

Slide 11: The Three Pillars of Infrastructure

Zus breaks its solution into three functional areas: Access, Meaning, and Value . Under 'Access,' the company claims to reach data on 90%+ of the U.S. population . 'Meaning' refers to the normalization of data into the FHIR (Fast Healthcare Interoperability Resources) standard, which is the industry's gold standard for data exchange. Finally, 'Value' is defined as the delivery of a positive ROI through task elimination and increased insight. This slide serves as the transition from the 'what' to the 'how.'

Slide 14: Integrating into the Workflow

A common failure in health-tech is requiring clinicians to log into a separate portal. Slide 14 addresses this by showing the Zus interface 'embedded in EHR or custom application for seamless access.' The slide lists heavy-hitting data network partners, including CommonWell Health Alliance, Carequality, Surescripts, and Quest Diagnostics . By showing the product living inside a dashboard (demohealth), Zus demonstrates that it is a 'plug-and-play' solution rather than a disruptive new workflow.

Slide 17: Qualitative Proof of Value

To balance the technical slides, Slide 17 utilizes testimonials from virtual care providers. An RN notes, 'I often look and realize I’ve been talking to a patient about their meds list for 30 minutes,' while a CPO mentions hiring a part-time employee solely for manual data entry. These quotes humanize the data problem, illustrating the 'soft' costs of poor information speed that Zus intends to eliminate.

Slide 21: The Transactional Business Model

This is perhaps the most important slide for a Series B investor. Zus presents a 'simple pricing structure' that is refreshingly transparent for the healthcare industry. It consists of:

ZAP Pull: $4.00 per patient (one-time fee for history). · ZAP Subscriber: $1.00 per enrolled patient per month (automated monthly updates). · ZAP Emergent: $2.00 per enrolled patient per month (real-time notifications for hospital transfers and lab results).

This model allows investors to easily project revenue based on patient volume, moving away from opaque enterprise licensing fees.

Slide 24: The Value Proposition for Distributors

Zus doesn't just sell to providers; they sell to the EHRs that providers use. Slide 24 quantifies the benefit for these channel partners. It claims a 'Small EHR reallocated $500K+ in developer resourcing ' by using Zus. Furthermore, it suggests that Zus can unlock an additional $120K+ per physician in annual revenue for customers. By showing how they make their partners more profitable, Zus demonstrates a clear path to viral distribution within the industry.

Slide 27: Enterprise Traction

Slide 27 is a 'logo slide' that indicates significant market validation. It lists inbound interest from Humana, CVS Health, Optum, Amazon Clinic, and Salesforce Health Cloud . For a Series B company, showing that the largest incumbents in the industry are knocking on the door is a powerful signal of product-market fit and future exit potential.

Slide 31: The Path to $32.5B

The deck concludes with a growth roadmap. Zus identifies a current market of $3.5B for its 'ZAP Pull' product with ~25% gross margins. As they move 'Beyond,' adding 'Informed Referrals' and a 'Payment Ledger,' they project a total addressable market (TAM) of $32.5B with incremental adjusted gross margins reaching ~100% . While the 100% margin claim is bold, it reflects the software-centric nature of their long-term vision where data acquisition costs are marginalized by scale.

What Zus Health Does Well

The deck is exceptionally good at quantifying the 'un-quantifiable' . Interoperability is a dry, technical subject, but Zus translates it into minutes saved per patient (20+ minutes) and dollars reallocated ($500K+). The pricing slide (Slide 21) is a standout; it removes the 'black box' of healthcare sales and presents a model that looks more like a modern API company (like Stripe or Plaid) than a legacy healthcare vendor. Finally, the use of the 'Access, Meaning, Value' framework (Slide 11) provides a clear mental model for how the platform actually works.

What is Missing from the Deck

Despite its strengths, there are notable omissions in the provided slides. There is no dedicated team slide showing the broader leadership beyond Jonathan Bush. While Bush is a 'celebrity' founder, investors at the Series B level typically want to see the bench strength in engineering and regulatory compliance. Additionally, while the deck mentions 'inbound interest,' it lacks a detailed case study with specific, audited outcomes from a long-term pilot. We see quotes and projections, but a slide dedicated to a 'Year 1' cohort's actual ROI would have strengthened the 'Proof' section. Finally, there is no explicit 'The Ask' slide in this sequence, though the publisher reports the round was $40M.

Founder's Playbook: What to Copy

Founders in complex industries should study Slide 21. If you can distill your complex service into a simple, transactional unit price , you make it significantly easier for investors to model your growth. Also, copy the 'Distributors' strategy from Slide 24. Instead of just showing how you help the end-user, show how you help the middleman (the channel partner) save money or reallocate resources. This is the key to scaling without a massive direct sales force. Lastly, the 'Problem' slide (Slide 7) is a perfect example of using multi-persona storytelling to show that a single pain point affects everyone from the patient to the developer.